Literature DB >> 17524517

Prevalence of the metabolic syndrome in Peruvian Andean hispanics: the PREVENCION study.

Josefina Medina-Lezama1, Humberto Zea-Diaz, Oscar L Morey-Vargas, Juan F Bolaños-Salazar, Edgar Muñoz-Atahualpa, Mauricio Postigo-MacDowall, Fernando Corrales-Medina, Zoila Valdivia-Ascuña, Carolina Cuba-Bustinza, Sheyla Paredes-Díaz, Paola Villalobos-Tapia, Julio Chirinos-Pacheco, Ronald B Goldberg, Julio A Chirinos.   

Abstract

Data regarding the prevalence of metabolic syndrome (MTS) in Andean populations are limited. We evaluated the prevalence of MTS according to American Heart Association/National Heart, Lung and Blood Institute criteria among 1878 subjects in the PREVENCION study in Peru. In women, the most common component was low HDL cholesterol (60.9%) followed by abdominal obesity (36.9%). In men, the most common component was elevated triglycerides (52.0%) followed by low HDL cholesterol (32.5%), whereas the prevalence of abdominal obesity was 14%. Abnormal fasting glucose was the least common component in men (5.4%) and women (5.0%). The prevalence of MTS was significantly higher in women compared to men (23.2% versus 14.3%) and increased steeply with age, particularly in women (p<0.0001). Using body mass index (BMI>or=30kg/m2) instead of waist circumference as a component of the MTS lead to equivalent prevalence estimates of MTS in men but significantly underestimated the prevalence in women. The MTS is highly prevalent among Peruvian Andeans, particularly in older women. The pattern of MTS components in this Andean population is characterized by a high prevalence of dyslipidemia and a relatively low prevalence of elevated fasting glucose. Further studies are required to characterize genetic and environmental determinants of these patterns.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17524517     DOI: 10.1016/j.diabres.2007.04.004

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  29 in total

Review 1.  The metabolic syndrome.

Authors:  Marc-Andre Cornier; Dana Dabelea; Teri L Hernandez; Rachel C Lindstrom; Amy J Steig; Nicole R Stob; Rachael E Van Pelt; Hong Wang; Robert H Eckel
Journal:  Endocr Rev       Date:  2008-10-29       Impact factor: 19.871

2.  Metabolic syndrome as an underlying disease entity and its relationship to subclinical atherosclerosis in Andean Hispanics.

Authors:  Diana A Chirinos; Josefina Medina-Lezama; William Arguelles; Ronald Goldberg; Neil Schneiderman; Zubair Khan; Oscar O Morey; Muhammad Waheed Raja; Roberto Paz; Julio A Chirinos; Maria M Llabre
Journal:  Metab Syndr Relat Disord       Date:  2013-11-08       Impact factor: 1.894

3.  Prevalence of metabolic syndrome and its relationship with leisure time physical activity among Peruvian adults.

Authors:  B Gelaye; L Revilla; T Lopez; S Sanchez; M A Williams
Journal:  Eur J Clin Invest       Date:  2009-06-26       Impact factor: 4.686

4.  Prevalence and determinants of hyperlipidemia in moderate altitude areas of the Yunnan-Kweichow plateau in Southwestern China.

Authors:  Bingjun Deng; Tingguang Luo; Yanfei Huang; Tianhang Shen; Jing Ma
Journal:  High Alt Med Biol       Date:  2012-03       Impact factor: 1.981

5.  Lipid profile and its association with risk factors for coronary heart disease in the highlanders of Lhasa, Tibet.

Authors:  Lhamo Y Sherpa; Hein Stigum; Virasakdi Chongsuvivatwong; Ouzhu Luobu; Dag S Thelle; Per Nafstad; Espen Bjertness
Journal:  High Alt Med Biol       Date:  2011       Impact factor: 1.981

6.  Interethnic differences in the accuracy of anthropometric indicators of obesity in screening for high risk of coronary heart disease.

Authors:  V M Herrera; J P Casas; J J Miranda; P Perel; R Pichardo; A González; J R Sanchez; C Ferreccio; X Aguilera; E Silva; M Oróstegui; L F Gómez; J A Chirinos; J Medina-Lezama; C M Pérez; E Suárez; A P Ortiz; L Rosero; N Schapochnik; Z Ortiz; D Ferrante; M Diaz; L E Bautista
Journal:  Int J Obes (Lond)       Date:  2009-02-24       Impact factor: 5.095

7.  Prevalence of the metabolic syndrome among rural original adults in NingXia, China.

Authors:  Zhao Yi; Jin Jing; Liu Xiu-ying; Xu Hongxia; Yang Jianjun; Zhang Yuhong
Journal:  BMC Public Health       Date:  2010-03-17       Impact factor: 3.295

8.  Prospective risk factors for increased central augmentation index in men and women.

Authors:  Prithvi Shiva Kumar; Josefina Medina-Lezama; Oscar Morey-Vargas; Payman Zamani; Juan F Bolaños-Salazar; Diana A Chirinos; Philip Haines; Zubair A Khan; Johanna C Coacalla-Guerra; Maria E Davalos-Robles; Gladys R Llerena-Dongo; Mardelangel Zapata-Ponze; Julio A Chirinos
Journal:  Am J Hypertens       Date:  2014-05-28       Impact factor: 2.689

9.  The Latin American Consortium of Studies in Obesity (LASO).

Authors:  L E Bautista; J P Casas; V M Herrera; J J Miranda; P Perel; R Pichardo; A González; J R Sanchez; C Ferreccio; X Aguilera; E Silva; M Oróstegui; L F Gómez; J A Chirinos; J Medina-Lezama; C M Pérez; E Suárez; A P Ortiz; L Rosero; N Schapochnik; Z Ortiz; D Ferrante
Journal:  Obes Rev       Date:  2009-05       Impact factor: 9.213

10.  Prevalence of the metabolic syndrome in Latin America and its association with sub-clinical carotid atherosclerosis: the CARMELA cross sectional study.

Authors:  Jorge Escobedo; Herman Schargrodsky; Beatriz Champagne; Honorio Silva; Carlos P Boissonnet; Raul Vinueza; Marta Torres; Rafael Hernandez; Elinor Wilson
Journal:  Cardiovasc Diabetol       Date:  2009-09-26       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.